Three year follow up of a phase III study investigating brentuximab vedotin combined with chemotherapy for first line treatment of advanced Hodgkin lymphoma.
Home / Resource Library / Brentuximab vedotin with chemotherapy for Stage III/IV classical Hodgkin lymphoma